R&D Systems™ Human TGF-beta 1.2 Recombinant Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Catalog Number	Mfr. No.	Formulation
304B3001	R&D Systems™ 304B3001	Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein.
304B3001CF	R&D Systems™ 304B3001/CF	Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA.

Description

The Recombinant Human TGF-beta 1.2 Protein is derived from Sf 21 (baculovirus). The Recombinant Human TGF-beta 1.2 Protein has been validated for the following applications: Bioactivity.

Specifications

• Molecular Weight (g/mol): 12.8 kDa (TGF-beta1) & 12.7 kDa (TGF-beta2)
• Purity: 97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Source: Spodoptera frugiperda,Sf 21 (baculovirus)-derived human TGF-beta 1.2 protein, (N-terminus) Human TGF-beta 1 (Ala279-Ser390) Accession &Num; P01137 Human TGF-beta 2 (Ala303-Ser414) Accession &Num; P61812 (C-terminus)
• Structural Form: Disulfide-linked heterodimer
• Recombinant: Yes

• Name: TGF-beta 1.2
• Quantity: 1μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Conjugate: Unconjugated